A new study published in the Journal of Bone and Mineral Research found that when older patients with osteoporotic hip ...

Zoledronic acid is a potent, new-generation bisphosphonate indicated for the treatment of documented bone metastasis in patients with solid tumors and bone lesions associated with multiple myeloma.

A serum creatinine measurement should be obtained within 10 days before the first infusion of zoledronic acid. Serum creatinine measurements should be obtained before each subsequent dose of ...

This pioneering test aids oncologists in predicting recurrence and survival rates in breast cancer patients and potential eligibility for bisphosphonate treatment. Results showing the clinical utility ...

The objectives of this symposium were to improve attendees’ knowledge on ADT, including the different therapeutic options ...